|
Index of reports
> Death (95)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to PEG-Intron (Peginterferon Alfa-2B) death. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 95 Next >>
Possible PEG-Intron side effects in
Reported by a physician from Italy on 2012-08-22
Patient:
Reactions: Multi-Organ Failure, Bronchopneumonia, Respiratory Acidosis, Pancytopenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
PEG-Intron
PEG-Intron
Dosage: 1200 mg, qw
Indication: Hepatitis C
Start date: 2012-04-23
End date: 2012-07-02
Rebetol
Dosage: 1200 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-23
End date: 2012-07-07
Victrelis
Dosage: unk, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-21
End date: 2012-07-07
Other drugs received by patient: Aspirin
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-22
Patient:
Reactions: Confusional State, Affect Lability, Completed Suicide, Platelet Count Decreased
Adverse event resulted in: death
Drug(s) suspected as cause:
PEG-Intron
Dosage: 80 microgram, qw
Start date: 2012-05-29
End date: 2012-06-05
PEG-Intron
Dosage: 120 microgram, qw
Indication: Hepatitis C
Start date: 2012-05-23
End date: 2012-05-23
Rebetol
Dosage: 1000 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-23
End date: 2012-06-01
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-21
Patient:
Reactions: Haemoglobin Decreased, Hepatic Failure
Adverse event resulted in: death
Drug(s) suspected as cause:
PEG-Intron
Dosage: 0.8mcg/kg/week
PEG-Intron
Dosage: 1.0mcg/kg/week
Indication: Hepatitis C
Start date: 2012-02-24
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-24
End date: 2012-04-25
Rebetol
Administration route: Oral
Start date: 2012-04-26
Telavic
Administration route: Oral
Start date: 2012-05-14
End date: 2012-06-01
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-24
End date: 2012-05-13
Possible PEG-Intron side effects in
Reported by a individual with unspecified qualification from Korea, Republic of on 2012-08-15
Patient:
Reactions: Major Depression
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Boceprevir
Dosage: 12 df, tid
Administration route: Oral
Start date: 2012-05-03
End date: 2012-05-30
Boceprevir
Dosage: 12 df, tid
Administration route: Oral
Start date: 2012-05-03
End date: 2012-05-30
Boceprevir
Dosage: 12 df, tid
Administration route: Oral
Start date: 2012-05-03
End date: 2012-05-30
Boceprevir
Dosage: 12 df, tid
Administration route: Oral
Start date: 2012-05-03
End date: 2012-05-30
PEG-Intron
Dosage: 1 df, qw
Indication: Hepatitis C
Start date: 2012-04-05
End date: 2012-05-30
Ribavirin
Dosage: 5 df, bid
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-05
End date: 2012-05-30
Ribavirin
Dosage: 5 df, bid
Administration route: Oral
Start date: 2012-04-05
End date: 2012-05-30
Possible PEG-Intron side effects in male
Reported by a individual with unspecified qualification from France on 2012-08-09
Patient: male, weighing 61.0 kg (134.2 pounds)
Reactions: Tooth Disorder
Adverse event resulted in: death, disablity
Drug(s) suspected as cause:
Blinded Post Trial Therapy
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Blinded Post Trial Therapy
Dosage: 800 mg, qd
Start date: 2007-10-18
End date: 2010-07-22
Blinded Post Trial Therapy
Dosage: 800 mg, qd
Start date: 2007-10-18
End date: 2010-07-22
Blinded PRE Trial Therapy
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Blinded PRE Trial Therapy
Dosage: 800 mg, qd
Start date: 2007-10-18
End date: 2010-07-22
Blinded PRE Trial Therapy
Dosage: 800 mg, qd
Start date: 2007-10-18
End date: 2010-07-22
PEG-Intron
Dosage: 30 ?g, qw
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Peginterferon Alfa-2B
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Peginterferon Alfa-2B
Dosage: 800 mg, qd
Start date: 2007-10-18
End date: 2010-07-22
Placebo
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Placebo
Dosage: 800 mg, qd
Start date: 2007-10-18
End date: 2010-07-22
Ribavirin
Dosage: 800 mg, qd
Start date: 2007-10-18
End date: 2010-07-22
Ribavirin
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from United States on 2012-08-07
Patient:
Reactions: Hepatic Cirrhosis
Adverse event resulted in: death
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1 df, qw
Indication: Hepatitis C
Rebetol
Indication: Hepatitis C
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from Colombia on 2012-08-07
Patient:
Reactions: Vomiting, Diabetes Mellitus, Diabetic Coma, Dizziness, Asthenia, Blood Glucose Increased
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
PEG-Intron
Other drugs received by patient: Omeprazole; Isoniazid; Acetaminophen; Ribavirin; Propranolol; Levothyroxine Sodium
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from Greece on 2012-08-01
Patient:
Reactions: Dyspnoea, Fatigue, Pulmonary Embolism, Pleural Effusion, Pyrexia, Cardiac Disorder
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 150 unk, unk
Indication: Hepatitis C
Start date: 2011-09-20
End date: 2012-07-03
Rebetol
Dosage: 1200 mg, unk
Indication: Hepatitis C
Start date: 2011-09-20
End date: 2012-07-03
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from United States on 2012-07-29
Patient:
Reactions: Death
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
PEG-Intron
Indication: Hepatitis C
Victrelis
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-27
Patient:
Reactions: Periorbital Oedema, Vomiting, Nausea, Insomnia, Disturbance in Attention
Adverse event resulted in: death
Drug(s) suspected as cause:
PEG-Intron
Dosage: 80 ?g, qw
Indication: Hepatitis C
Start date: 2012-01-23
Ribasphere
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2012-01-27
Victrelis
Dosage: 800 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-21
Other drugs received by patient: Zoloft; Neupogen; Procrit
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-07-27
Patient:
Reactions: Weight Decreased, Hypogeusia, Chills, Oropharyngeal Pain, Death, Cheilitis, Feeling of Body Temperature Change, Pharyngitis, White Blood Cell Count Decreased, Dysphagia, Vomiting, Stomatitis, Anaemia, Full Blood Count Decreased, Haemoglobin Decreased, Dysgeusia, Diarrhoea, Dehydration, Asthenia, Aphonia, Influenza Like Illness
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-05-04
End date: 2012-06-29
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2012-05-04
End date: 2012-06-29
Victrelis
Dosage: unk
Indication: Hepatitis C
Start date: 2012-06-08
End date: 2012-06-29
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-07-26
Patient:
Reactions: Anaemia, Thrombocytopenia, Leukopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
PEG-Intron
Dosage: 180 microgram, qw
Indication: Hepatitis C
Start date: 2011-10-21
Rebetol
Dosage: 600 mg, qd
Start date: 2012-05-16
Rebetol
Dosage: 800 mg, qd
Start date: 2012-05-03
End date: 2012-05-15
Rebetol
Dosage: 1200 mg, qd
Indication: Hepatitis C
Start date: 2011-10-21
End date: 2012-05-02
Victrelis
Dosage: 2400 mg, qd
Indication: Hepatitis C
Start date: 2011-12-21
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from United States on 2012-07-26
Patient:
Reactions: Death
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
PEG-Intron
Indication: Hepatitis C
Victrelis
Possible PEG-Intron side effects in
Reported by a individual with unspecified qualification from France on 2012-07-26
Patient:
Reactions: Tooth Disorder
Adverse event resulted in: death, disablity
Drug(s) suspected as cause:
Blinded Post Trial Therapy
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Blinded Post Trial Therapy
Dosage: 800 mg, qd
Start date: 2007-10-18
End date: 2010-07-22
Blinded PRE Trial Therapy
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Blinded PRE Trial Therapy
Dosage: 800 mg, qd
Start date: 2007-10-18
End date: 2010-07-22
PEG-Intron
Dosage: 30 ?g, qw
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Peginterferon Alfa-2B
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Placebo
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Ribavirin
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from United States on 2012-07-25
Patient:
Reactions: Dyspnoea, Syncope, Wrong Technique in Drug Usage Process, Blood Pressure Decreased, Asthenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 120 micrograms, qw
Indication: Hepatitis C
Start date: 2012-05-01
Rebetol
Indication: Hepatitis C
Other drugs received by patient: Lisinopril; Ondansetron; Effexor; Synthroid; Paxil; Tranxene
Possible PEG-Intron side effects in
Reported by a physician from Italy on 2012-07-25
Patient:
Reactions: Multi-Organ Failure, Bronchopneumonia, Respiratory Acidosis, Pancytopenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
PEG-Intron
PEG-Intron
Dosage: 1200 mg, qw
Indication: Hepatitis C
Start date: 2012-04-23
End date: 2012-07-02
Rebetol
Dosage: 1200 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-23
End date: 2012-07-07
Victrelis
Dosage: unk, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-21
End date: 2012-07-07
Other drugs received by patient: Aspirin
Possible PEG-Intron side effects in
Reported by a physician from Greece on 2012-07-24
Patient:
Reactions: Dyspnoea, Fatigue, Pleural Effusion, Pulmonary Embolism, Pyrexia, Cardiac Disorder
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 150 unk, unk
Indication: Hepatitis C
End date: 2012-07-03
Rebetol
Dosage: 1200 microgram, unk
Indication: Hepatitis C
End date: 2012-07-03
Possible PEG-Intron side effects in
Reported by a physician from Germany on 2012-07-20
Patient:
Reactions: Vomiting, Renal Failure, Sepsis, Urinary Tract Infection, Hepatic Failure
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Copegus
Dosage: 1600 mg
Indication: Hepatitis C
Start date: 2012-01-05
End date: 2012-06-19
PEG-Intron
Dosage: 180 micg, qw
Indication: Hepatitis C
Start date: 2012-01-05
End date: 2012-06-19
Victrelis
Dosage: 3 x 800
Indication: Hepatitis C
Start date: 2012-02-02
End date: 2012-06-19
Other drugs received by patient: Citalopram Hydrobromide; Haloperidol; Metoclopramide; Lercanidipine; Mirtazapin Stada; Ramipril
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from United States on 2012-07-20
Patient:
Reactions: Hypogeusia, Glossodynia, Tinnitus, Hypoaesthesia Oral
Adverse event resulted in: death
Drug(s) suspected as cause:
PEG-Intron
Indication: Hepatitis C
Ribavirin
Indication: Hepatitis C
Victrelis
Dosage: 800 mg, q8h
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-11
Possible PEG-Intron side effects in
Reported by a physician from Netherlands on 2012-07-19
Patient:
Reactions: Pancreatitis
Adverse event resulted in: death
Drug(s) suspected as cause:
PEG-Intron
Indication: Hepatitis C
Rebetol
Indication: Hepatitis C
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-19
Patient:
Reactions: Bowel Movement Irregularity, Tinnitus, Anaemia, Feeling Hot, Loss of Consciousness
Adverse event resulted in: death, hospitalization, disablity
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2011-07-22
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2011-07-22
Victrelis
Dosage: unk
Indication: Hepatitis C
Start date: 2011-08-20
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from Colombia on 2012-07-18
Patient:
Reactions: Atelectasis, Respiratory Failure
Adverse event resulted in: death
Drug(s) suspected as cause:
PEG-Intron
Dosage: 80 microgram, qd
Start date: 2012-06-22
End date: 2012-06-24
PEG-Intron
Dosage: 80 microgram, qd
Indication: Hepatitis B
Start date: 2012-06-15
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from United States on 2012-07-18
Patient:
Reactions: Drug Dose Omission, Burning Sensation, Pruritus, DRY Skin, Erythema
Adverse event resulted in: death
Drug(s) suspected as cause:
PEG-Intron
Other drugs received by patient: Ondansetron; Prilosec; Metformin Hydrochloride; Ibuprofen
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from United States on 2012-07-17
Patient:
Reactions: Malaise, Injection Site Rash
Adverse event resulted in: death
Drug(s) suspected as cause:
PEG-Intron
Possible PEG-Intron side effects in
Reported by a individual with unspecified qualification from Germany on 2012-07-17
Patient:
Reactions: Aphthous Stomatitis, Pruritus, Stomatitis, Anaemia, Aggression, Middle Insomnia, Syncope, Mood Altered, NO Therapeutic Response, Thrombocytopenia, Leukopenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Start date: 2011-10-28
End date: 2011-12-07
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2010-08-20
End date: 2010-11-29
PEG-Intron
Dosage: 80 a?g, qw
Start date: 2011-12-01
PEG-Intron
Dosage: 64 a?g, qw
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Start date: 2011-10-28
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2010-08-20
End date: 2010-11-29
Victrelis
Dosage: 2400 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-11-23
Other drugs received by patient: Opipramol Hydrochloride; Citalopram Hydrobromide; Amitriptyline HCL
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from United States on 2012-07-17
Patient:
Reactions: Influenza Like Illness
Adverse event resulted in: death
Drug(s) suspected as cause:
PEG-Intron
Dosage: 120 a?g, qw
Indication: Hepatitis C
Start date: 2012-01-01
Ribavirin
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Antiviral (Unspecified)
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from United States on 2012-07-16
Patient:
Reactions: Injury Associated With Device
Adverse event resulted in: death
Drug(s) suspected as cause:
PEG-Intron
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-07-11
Patient:
Reactions: Irritability, Completed Suicide
Adverse event resulted in: death
Drug(s) suspected as cause:
PEG-Intron
Dosage: 100 microgram, qw
Indication: Hepatitis C
Start date: 2012-05-01
End date: 2012-06-01
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-01
End date: 2012-06-01
Possible PEG-Intron side effects in
Reported by a physician from Germany on 2012-07-11
Patient:
Reactions: Vomiting, Renal Failure, Urinary Tract Infection, Hepatic Failure
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Copegus
Dosage: 1600 mg
Indication: Hepatitis C
Start date: 2012-01-05
End date: 2012-06-19
PEG-Intron
Dosage: 180 micg, qw
Indication: Hepatitis C
Start date: 2012-01-05
End date: 2012-06-19
Victrelis
Dosage: 3 x 800
Indication: Hepatitis C
Start date: 2012-02-02
End date: 2012-06-19
Other drugs received by patient: Ramipril; Haloperidol; Metoclopramide; Lercanidipine; Mirtazapin Stada; Citalopram Hydrobromide
Possible PEG-Intron side effects in
Reported by a individual with unspecified qualification from United States on 2012-07-11
Patient:
Reactions: Inappropriate Schedule of Drug Administration
Adverse event resulted in: death
Drug(s) suspected as cause:
PEG-Intron
Page 1 Next >>
|
